Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 12,061Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 28Pfizer Inc

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

BIO-Europe Spring
Not Confirmed
arrow
arrow
BIO-Europe Spring
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.25MG BASE

Packaging :

Approval Date : 2018-10-16

Application Number : 211651

Regulatory Info : DISCN

Registration Country : USA

blank

02

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2018-10-16

Application Number : 211651

Regulatory Info : DISCN

Registration Country : USA

blank

03

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.5MG BASE

Packaging :

Approval Date : 2021-09-20

Application Number : 211651

Regulatory Info : DISCN

Registration Country : USA

blank

04

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.75MG BASE

Packaging :

Approval Date : 2021-09-20

Application Number : 211651

Regulatory Info : DISCN

Registration Country : USA

blank

05

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.1MG BASE

Packaging :

Approval Date : 2023-06-20

Application Number : 211651

Regulatory Info : DISCN

Registration Country : USA

blank

06

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.35MG BASE

Packaging :

Approval Date : 2023-06-20

Application Number : 211651

Regulatory Info : DISCN

Registration Country : USA

blank

07

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.1MG BASE

Packaging :

Approval Date : 2024-03-07

Application Number : 217439

Regulatory Info : RX

Registration Country : USA

blank

08

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.25MG BASE

Packaging :

Approval Date : 2024-03-07

Application Number : 217439

Regulatory Info : RX

Registration Country : USA

blank

09

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.35MG BASE

Packaging :

Approval Date : 2024-03-07

Application Number : 217439

Regulatory Info : RX

Registration Country : USA

blank

10

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.5MG BASE

Packaging :

Approval Date : 2024-03-07

Application Number : 217439

Regulatory Info : RX

Registration Country : USA

blank

11

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 0.75MG BASE

Packaging :

Approval Date : 2024-03-07

Application Number : 217439

Regulatory Info : RX

Registration Country : USA

blank

12

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

TALAZOPARIB TOSYLATE

Brand Name : TALZENNA

Dosage Form : CAPSULE;ORAL

Dosage Strength : EQ 1MG BASE

Packaging :

Approval Date : 2024-03-07

Application Number : 217439

Regulatory Info : RX

Registration Country : USA

blank

13

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Talazoparibtosylat

Brand Name : Talzenna

Dosage Form : Capsule

Dosage Strength : 0.1mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

14

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Talazoparibtosylat

Brand Name : Talzenna

Dosage Form : Capsule

Dosage Strength : 0.25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

15

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Talazoparibtosylat

Brand Name : Talzenna

Dosage Form : Capsule

Dosage Strength : 1mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

16

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Talazoparib Tosylate

Brand Name : Talzenna

Dosage Form : Hard Capsule

Dosage Strength : 1MG

Packaging :

Approval Date : 11-09-2019

Application Number : 1191377005

Regulatory Info : Authorized

Registration Country : Spain

blank

17

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Talazoparib Tosylate

Brand Name : Talzenna

Dosage Form : Hard Capsule

Dosage Strength : 0.1MG

Packaging :

Approval Date : 15-01-2024

Application Number : 191377007

Regulatory Info : Authorized

Registration Country : Spain

blank

18

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Talazoparib Tosylate

Brand Name : Talzenna

Dosage Form : Hard Capsule

Dosage Strength : 0.25MG

Packaging :

Approval Date : 24-07-2019

Application Number : 1191377001

Regulatory Info : Authorized

Registration Country : Spain

blank

19

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Talazoparib Tosilate

Brand Name : Talzenna

Dosage Form : Hard Capsules

Dosage Strength : 0.1mg

Packaging :

Approval Date : 05-01-2024

Application Number : 28106916023

Regulatory Info : Prescription

Registration Country : Denmark

blank

20

DCAT Week
Not Confirmed
arrow
arrow
DCAT Week
Not Confirmed

Talazoparib Tosilate

Brand Name : Talzenna

Dosage Form : Hard Capsules

Dosage Strength : 0.25mg

Packaging :

Approval Date : 20-06-2019

Application Number : 28106121818

Regulatory Info : Prescription

Registration Country : Denmark

blank